Correlation Between Surrozen and Protara Therapeutics

Can any of the company-specific risk be diversified away by investing in both Surrozen and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Surrozen and Protara Therapeutics, you can compare the effects of market volatilities on Surrozen and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and Protara Therapeutics.

Diversification Opportunities for Surrozen and Protara Therapeutics

0.54

Correlation Coefficient

Surrozen  Protara Therapeutics

Very weak diversification

The 3 months correlation between Surrozen and Protara is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Surrozen i.e., Surrozen and Protara Therapeutics go up and down completely randomly.

Pair Corralation between Surrozen and Protara Therapeutics

Given the investment horizon of 90 days Surrozen is expected to under-perform the Protara Therapeutics. In addition to that, Surrozen is 1.25 times more volatile than Protara Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Protara Therapeutics is currently generating about -0.03 per unit of volatility. If you would invest  528.00  in Protara Therapeutics on December 29, 2024 and sell it today you would lose (70.00) from holding Protara Therapeutics or give up 13.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Surrozen  vs.  Protara Therapeutics

Surrozen

Risk-Adjusted Performance

Very Weak

Over the last 90 days Surrozen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Protara Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Protara Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Surrozen and Protara Therapeutics

The main advantage of trading using opposite Surrozen and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.

The idea behind Surrozen and Protara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.